• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.65% Nasdaq Down1.89%

    Insulet Corporation (PODD)

    -NasdaqGS
    31.31 Up 0.01(0.03%) 4:00PM EST
    |After Hours : 31.31 0.00 (0.00%) 4:50PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Insulet Corporation
    9 Oak Park Drive
    Bedford, MA 01730
    United States - Map
    Phone: 781-457-5000
    Fax: 781-457-5011
    Website: http://www.insulet.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:478

    Business Summary 

    Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod, a disposable insulin infusion device that integrates an infusion set, automated cannula insertion, insulin reservoir, drive mechanism, and batteries; and a handheld, wireless personal diabetes manager. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors. Insulet Corporation was founded in 2000 and is based in Bedford, Massachusetts.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Insulet Corporation

    Corporate Governance 
    Insulet Corporation’s ISS Governance QuickScore as of Jan 1, 2015 is 10. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 10; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Charles T. Liamos , 55
    Director of Advanced Technology and Director
    563.00K2.57M
    Mr. R. Anthony Diehl Esq., 46
    Gen. Counsel and Sec.
    406.00K935.00K
    Mr. Peter J. Devlin , 47
    Exec. Officer
    452.00K1.11M
    Mr. Patrick J. Sullivan , 63
    Chief Exec. Officer, Pres and Director
    N/AN/A
    Ms. Allison Dorval ,
    Chief Financial Officer
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders